Ph II Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head and Neck Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Gefitinib (Primary) ; Carboplatin; Fluorouracil; Hydroxycarbamide; Paclitaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 08 Sep 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.
- 08 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Jul 2018.
- 05 Jul 2017 Planned End Date changed from 1 Sep 2017 to 1 Aug 2017.